학술논문

POSC34 Comparative Efficacy and Safety of Isatuximab Plus Pomalidomide and Dexamethasone Versus Daratumumab Plus Pomalidomide and Dexamethasone in Patients with Multiple Myeloma Using a Matching-Adjusted Indirect Comparison
Document Type
Abstract
Source
In Value in Health January 2022 25(1) Supplement:S39-S39
Subject
Language
ISSN
1098-3015